you crypto Top Block

During the battle of AI glasses, several new financings were under way in the field of AI glasses, among which Viture, which focuses on AR game scenes, and Even Realities, whose current product form is mainly a combination of AI and AR, have entered the late stage of the transaction, and their latest valuations both exceed 100 million US dollars. It is understood that Wang Huiwen, co-founder of Meituan, also recently invested in Viture. The old shareholders of this company founded in 2021 include Lanchi Venture Capital, BAI Capital and Zhenzhi Venture Capital. (latepost)The Bank of Italy said that the economy may only grow by 0.5% this year, and the Bank of Italy said in a statement on Friday that the gross domestic product (GDP) will increase by 0.5% in 2024. If seasonal and calendar effects are not taken into account, this figure will increase to 0.7%, but it is lower than the government's estimate of 1% in the budget. In addition, GDP growth is expected to be 0.8% in 2025 and 1.1% in 2026. It is estimated that the unified average inflation rate in the EU will be 1.1% in 2024, which is the same as the estimated value in October, 1.5% in 2025 and 1.6% in 2025.Israel pressured the Palestinian National Authority to search for militants. The Palestinian National Authority admitted on the 12th that Palestinian security forces killed a 19-year-old civilian man during an operation in the West Bank city of Jenin earlier this week. Palestinian Islamic Resistance Movement (Hamas) accused the Palestinian National Authority of searching for "resistance fighters" and said that Palestine should avoid internal conflicts. According to Israeli media reports, the Israeli side pressured the Palestinian National Authority to intensify the search, and threatened that if the Palestinian security forces could not do it, the Israeli army would do it. (Xinhua News Agency)

The grain output of Inner Mongolia exceeded 80 billion Jin for the first time. The reporter learned from the Agriculture and Animal Husbandry Department of Inner Mongolia Autonomous Region on December 13th that according to the latest data released by the National Bureau of Statistics, the grain output of Inner Mongolia exceeded 80 billion Jin for the first time this year, reaching 82.01 billion Jin, achieving a bumper harvest for 21 consecutive years. (Xinhua News Agency)On December 13th, Shaanxi Supervision Bureau of the State Financial Supervision and Administration issued an administrative penalty message showing that Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was fined 60,000 yuan for giving benefits other than the insurance contract. The salesman of Baoji Central Branch of Ancheng Property Insurance Co., Ltd. was warned and fined 10,000 yuan.Keheng shares: signed a cooperation framework agreement with Gree supply chain, and Keheng shares announced that the company and its wholly-owned subsidiaries Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology signed a cooperation framework agreement with Gree supply chain. Gree supply chain granted Jiangmen Keheng, Yingde Keheng, Zhuhai Keheng, Zhuhai Haoneng and Haoneng Technology a total of 650 million yuan in raw material procurement business.

Daye shares: the proposed acquisition of 100% equity of Al-Kogerte GmbH constitutes a major asset restructuring. Daye shares announced that the company intends to acquire 100% equity of Al-Kogerte GmbH in cash through its wholly-owned subsidiary RUNBO INT PTE.LTD, which constitutes a major asset restructuring of the company.Kexing launched the world's first phase III clinical study of bivalent inactivated enterovirus vaccine. On December 13th, the first volunteer was enrolled in the phase III clinical study of bivalent inactivated enterovirus vaccine developed by Beijing Kexing Biological Products Co., Ltd., a subsidiary of Kexing Holding Biotechnology Co., Ltd. (hereinafter referred to as "Kexing"). The vaccine is used to prevent hand, foot and mouth disease caused by enterovirus 71 (EV71) and coxsackie virus 16 (CA16). A multicenter, randomized, double-blind, controlled study design was adopted in this phase III clinical study to evaluate the protective efficacy, safety and immunogenicity of the vaccine in children aged 6-71 months.Market News: Argentine President Milei met with Rio Tinto CEO Meloni in Rome.